Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Down Syndrome patients with Alopecia Areata often have hypothyroidism and specific immune abnormalities.

CCCA may be caused by both hair traction and an immune response.

Early diagnosis and treatment of myositis in SLE patients lead to positive outcomes.

BST2 is highly expressed in certain immune cells in alopecia areata, suggesting a role in the disease.

Discoid lupus erythematosus involves immune activation and fibrosis around hair follicles, with shared pathways across humans, dogs, and mice, suggesting potential treatments for both humans and animals.

Telitacicept helped stabilize complement levels in a patient with lupus and thyroid cancer.

Different immune responses cause hair loss in scalp diseases, with unique patterns in scalp psoriasis possibly protecting against hair loss.

A 13-year-old girl was diagnosed with juvenile lupus, showing only hair loss as a symptom.

A woman with lupus had blood cell destruction, treated successfully with medication.

Patients with Systemic Sclerosis have much higher levels of GDF-15, which could help predict organ involvement and guide treatment.

Rash in SLE patients indicates more severe disease.

Tranexamic acid effectively reduced swelling episodes in a girl with a rare form of hereditary angioneurotic edema.

SLE in ageing patients is less severe and needs careful treatment to avoid excess.

The telogen phase of hair growth is active and important for preparing hair follicles for regeneration, not just a resting stage.

Skin spheroids with both outer and inner layers are key for regrowing skin patterns and hair.

A woman with subacute cutaneous lupus erythematosus had widespread skin symptoms triggered by medication and sunlight, which improved with specific treatments.

Recognizing LET and AITD can help diagnose SLE early for better treatment.

A woman in Sri Lanka was diagnosed with lupus after presenting with protein loss from the gut and other symptoms.

It's unclear if COVID-19 vaccination causes SLE; more research is needed.

Religious headwear can cause hair loss, so dermatologists should offer culturally sensitive advice to prevent it.

Current models for studying alopecia are inadequate, and more human-like systems are needed.

Migrant and minority communities face higher rates of alopecia due to genetic, environmental, and cultural factors, needing better healthcare access and culturally aware treatments.

Inclusive and culturally competent healthcare is crucial for transgender and non-binary individuals.

The document concludes that health care providers should offer culturally competent care and more research is needed to improve health outcomes for transgender individuals.

Healthcare providers need better education and resources to give competent and sensitive care to transgender patients.

Hair transplantation has improved to more natural-looking results and is complemented by effective non-surgical treatments, with ongoing research into hair follicle cloning.

Current SLE classifications need refinement, and the complement system is a key therapeutic target.

Dr. Samuel M. Lam's article concludes that skilled facial fat grafting can effectively restore facial volume and serve as a complement or alternative to traditional face-lifting methods.

LGBT individuals have unique skin health needs, including higher STD risks and side effects from gender-affirming treatments, requiring dermatologists to offer knowledgeable and culturally competent care.

Red LED therapy may help reduce hair loss and improve hair health in Telogen Effluvium.